The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).

After every meal, the intestines perform an action called peristalsis - moving food through their hollow interiors with coordinated contractions and relaxations of the smooth muscle.

GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...

Research in mice identifies protein responsible for regulating gut movement in response to pressure, exercise, and ...

Under the BioVersys and GSK collaboration agreement, GSK is evaluating the early bactericidal activity (EBA) of alpibectir-ethionamide (AlpE) in a pulmonary tuberculosis (TB) trial, in combination ...

Also joining the board of directors is Tal Zaks, former chief medical officer of Moderna. Zaks oversaw the development of ...

GSK is a #3 (Hold) on the Zacks Rank, with a VGM Score of A. Momentum investors should take note of this Medical stock. GSK has a Momentum Style Score of A, and shares are up 7.3% over the past four ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

Mumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Carson Dalton as Executive Vice President, Communications and Government Affairs effective 3rd March 2025. Ransom ...

The drug also nearly eliminated the need for future surgery and corticosteroid use, Joseph Han, M.D., from the Eastern Virginia Medical School ... than results for GSK’s depemokimab.

“With nearly 40% of patients needing repeat surgeries and many requiring long-term systemic corticosteroids, there is a clear medical need for alternative treatment options.” GSK presented the ...

3 According to GSK, approximately 26 million people in the United States ... surgeries and many requiring long-term systemic corticosteroids, there is a clear medical need for alternative treatment ...